Tech

Week In Review: Sino Biopharm Subsidiary Enters $307 Million Agreement For Rights To NASH Candidate


Deals And Financings Chia Tai-Tianqing Pharma, a subsidiary of Sino Biopharm (OTCPK:SBMFF), in-licensed Greater China rights to a therapy for …

Read more at seekingalpha.com

Show More
Back to top button